Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
Clinical trial NCT02882269 · UNKNOWN
Trial details
- NCT number
- NCT02882269
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2021-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.